Ventrica


Public lists: Medical Devices (6162)

Ventrica, Inc. is developing a new generation of heart bypass devices designed to revascularize coronary arteries by shunting blood directly from the left ventricle of the heart and thus tapping into the body's natural source of oxygenated blood. This approach has the ability to significantly change the way conventional coronary artery bypass graft surgery is performed.

Ventrica, Inc. is developing a new generation of heart bypass devices designed to revascularize coronary arteries by shunting blood directly from the left ventricle of the heart and thus tapping into the body's natural source of oxygenated blood. Thi...Show all

Company (Acquired)

Phone: 510-438-7100

Fax:

5055 Brandin Court

Fremont, 94538
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ventrica $25.5M Dec 20, 2004
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ventrica Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Devices for Vascular Intervention

Indianapolis, Indiana, United States
Alive / ActiveDevices for Vascular Interventions offers atherectomy systems for removal of plaque from coronary arteriesLogin to see details

Satiety

Palo Alto, California, United States
Alive / ActiveSatiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first produc...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)